Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Dermatology | Rheumatology | Family Medicine
Disease Category: Psoriasis and Psoriatic Disorders
Location: United States, CA
A Phase 3, Multi-site, randomized, mixed-blind, parallel-group treatment withdrawl and re-treatment study of the efficacy and safety of 2 oral doses of CP-690,550 in Subjects with Moderate to Severe Chronic Plaque Psoriasis
Patient Inclusion Criteria:
- 18+ years of age
- Diagnosis of stable plaque psoriasis
- Moderate to severe
- Covering at least 10% of total body surface area
Patient Exclusion Criteria:
- Currently have non-plaque forms of psoriasis, eg, erythrodermic, guttate, or pustular psoriasis
Dermatology Specialists, Inc.
3629 Vista Way
Oceanside, CA 92056
Research Center Information: Dermatology Specialists, Inc.
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these